Active Filter(s):
Details:
Results from a recent pilot study showed that SJP-001, comprising a combination of naproxen and fexofenadine was significantly more effective in reducing alcohol hangover severity than placebo.
Lead Product(s): Naproxen,Fexofenadine Hydrochloride
Therapeutic Area: Psychiatry/Psychology Product Name: SJP-001
Highest Development Status: IND Enabling Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 17, 2022